Observational registry evaluates clinical outcomes following middle meningeal artery embolization for chronic subdural hematoma, suggesting new insights into therapy.
Key Points
Hematoma recurrence requiring reintervention within 180 days will be the primary effectiveness outcome.
The study aims to enroll 200 adults diagnosed with chronic subdural hematoma and undergoing embolization with coils.
Analysis will focus on clinical outcomes including hospital readmissions and changes in functional status at 90 days.
Data collected aims to inform best practices and enhance the understanding of embolization in clinical settings.